Genetic Clues to the Pathogenesis of Parkinson's Disease

Overview

Journal Nat Med

Specialties General Medicine
Molecular Biology

Date 2004 Jul 24

PMID 15272270

Citations 85

Authors

Miquel Vila

Serge Przedborski

Affiliations

Soon will be listed here.

Abstract

Recent years have seen an explosion in the rate of discovery of genetic defects linked to Parkinson's disease. These breakthroughs have not provided a direct explanation for the disease process. Nevertheless, they have helped transform Parkinson's disease research by providing tangible clues to the neurobiology of the disorder.

Citing Articles

Cobra Venom Cytotoxins as a Tool for Probing Mechanisms of Mitochondrial Energetics and Understanding Mitochondrial Membrane Structure.

Gasanoff E, Dagda R Toxins (Basel). 2024; 16(7).

PMID: 39057927 PMC: 11281317. DOI: 10.3390/toxins16070287.

Ion Channels and Metal Ions in Parkinson's Disease: Historical Perspective to the Current Scenario.

Vaidya B, Padhy D, Joshi H, Sharma S, Singh J Methods Mol Biol. 2024; 2761:529-557.

PMID: 38427260 DOI: 10.1007/978-1-0716-3662-6_36.

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson's disease models.

Arcos J, Grunenwald F, Sepulveda D, Jerez C, Urbina V, Huerta T Cell Death Discov. 2023; 9(1):438.

PMID: 38042807 PMC: 10693583. DOI: 10.1038/s41420-023-01734-1.

Unravelling the Parkinson's puzzle, from medications and surgery to stem cells and genes: a comprehensive review of current and future management strategies.

Chandrababu K, Radhakrishnan V, Anjana A, Rajan R, Sivan U, Krishnan S Exp Brain Res. 2023; 242(1):1-23.

PMID: 38015243 DOI: 10.1007/s00221-023-06735-1.

Protection of dopaminergic neurons in hemiparkinsonian monkeys by flavouring ingredient glyceryl tribenzoate.

Rangasamy S, Dutta D, Mondal S, Majumder M, Dasarathy S, Chandra G NeuroImmune Pharm Ther. 2023; 1(1):7-22.

PMID: 36720111 PMC: 9212717. DOI: 10.1515/nipt-2022-0005.